George Kelly Martin

Insider Reports History

Entity
Individual
Location
C/O Trisalus Life Sciences, Inc., 6272 W. 91 St Avenue, Westminster, CO
Signature
/s/ Sean Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Kelly Martin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Director Common Stock 247K $1.36M $5.50 Aug 28, 2024 By Varka LLC
TriSalus Life Sciences, Inc. Director Director stock option (right to buy) 15K Aug 13, 2024 Direct

Insider Reports Filed by George Kelly Martin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLSI TriSalus Life Sciences, Inc. Aug 28, 2024 1 -$50 4 Sep 10, 2024 Director
TLSI TriSalus Life Sciences, Inc. Aug 13, 2024 1 $0 4 Aug 21, 2024 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 0 $0 3/A May 21, 2024 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 0 $0 3 Aug 14, 2023 Director